IPCIF - Intellipharmaceutics International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 3.10
52-Week Change 34.21%
S&P500 52-Week Change 318.89%
52 Week High 30.4300
52 Week Low 30.0900
50-Day Moving Average 30.1443
200-Day Moving Average 30.1948

Share Statistics

Avg Vol (3 month) 392.73k
Avg Vol (10 day) 3197.38k
Shares Outstanding 522.09M
Float 16.27M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Feb 28, 2019) 4714k
Short Ratio (Feb 28, 2019) 40.39
Short % of Float (Feb 28, 2019) 43.35%
Short % of Shares Outstanding (Feb 28, 2019) 43.26%
Shares Short (prior month Jan 31, 2019) 4211.76k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Sep 14, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Nov 30, 2018
Most Recent Quarter (mrq)Aug 31, 2019


Profit Margin -289.80%
Operating Margin (ttm)-277.35%

Management Effectiveness

Return on Assets (ttm)-128.66%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)3.64M
Revenue Per Share (ttm)0.20
Quarterly Revenue Growth (yoy)308.60%
Gross Profit (ttm)1.59M
Net Income Avi to Common (ttm)-10.54M
Diluted EPS (ttm)-0.5910
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)54.36k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.53M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.27
Book Value Per Share (mrq)-0.11

Cash Flow Statement

Operating Cash Flow (ttm)-12.5M
Levered Free Cash Flow (ttm)-6.85M